Synthetic Hydrogel Platform for Tunable Stiffness and Cytocompatibility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic hydrogels face challenges in achieving precisely tunable stiffness, plasticity, and degradative properties for controlled cell encapsulation and release, with limitations in modulating biophysical and degradative properties of natural polymers and cytotoxicity issues with radical initiators in photo-crosslinked polymers.
Innovation Solution
Development of a novel 3D synthetic hydrogel platform with biorthogonal covalent and non-covalent crosslinking of cytocompatible building blocks, allowing for predictive tuning of stiffness, viscoelasticity, and degradation through controlled ratios of covalent and physical crosslinks, and strategic placement of stable and labile linkages.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If natural polymer-based hydrogels are used for cell encapsulation, then cytocompatibility is improved, but batch-to-batch variation and contamination risks worsen manufacturing precision and reliability
Solution Approach 1:
The patent changes the fundamental parameter of hydrogel composition from natural polymers to wholly synthetic polymers (PEG-based), eliminating batch-to-batch variation and contamination risks while maintaining cytocompatibility through careful design of the synthetic polymer architecture and crosslinking chemistry
Solution Approach 2:
The patent creates a composite hydrogel system combining PEG polymers with specific crosslinking agents (copper catalyst and ligands) to achieve both manufacturing precision of synthetic materials and the biological compatibility required for cell encapsulation
2Strength
If photo-crosslinked polymethacrylate-based hydrogels are used to modulate stiffness, then mechanical properties are improved, but radical initiators and photo-irradiation cause cytotoxicity
Solution Approach 1:
The patent extracts and removes the harmful radical initiators and photo-irradiation steps from the crosslinking process, replacing them with a copper-catalyzed click chemistry approach that achieves the same stiffness modulation without cytotoxic byproducts
Solution Approach 2:
The patent substitutes the photochemical crosslinking mechanism with a copper-catalyzed chemical crosslinking mechanism, replacing light-based activation with a chemical catalyst-based approach that is cytocompatible and provides equivalent mechanical property control
3Stability of the object's composition
If covalent crosslinking is increased to control degradation, then structural stability is improved, but matrix plasticity and cell release capability worsen
Solution Approach 1:
The patent segments the crosslinking system into two distinct components: stable covalent crosslinks for structural integrity and dynamic metal-coordinating crosslinks for plasticity and controlled degradation, allowing both structural stability and adaptability to coexist in the same hydrogel network
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogel platform enables long-term encapsulation and timed release of cells with maintained chondrogenic phenotype, addressing the limitations of existing hydrogels by providing a synthetic niche for cell proliferation and matrix deposition with controlled mechanical properties.
Implementation Method 1
biorthogonal covalent and non-covalent crosslinking of cytocompatible building blocks
Implementation Method 2
biorthogonal covalent and non-covalent crosslinking of cytocompatible building blocks
Implementation Method 3
predictive tuning of stiffness, viscoelasticity, and degradation through controlled ratios of covalent and physical crosslinks
Data Source
AI summary
The invention provides a novel, versatile degradable hydrogel composition, and methods thereof, with precisely tunable stiffness, plasticity (e.g., degree of covalent vs. physical crosslinks) and predictive disintegration rates degradation, allowing controlled disintegration and release of therapeutic cells or pharmaceuticals and/or in vitro 3D cell expansion.